These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


393 related items for PubMed ID: 12429644

  • 21. Flavopiridol sensitivity of cancer cells isolated from ascites and pleural fluids.
    Richard C, Matthews D, Duivenvoorden W, Yau J, Wright PS, Th'ng JP.
    Clin Cancer Res; 2005 May 01; 11(9):3523-9. PubMed ID: 15867255
    [Abstract] [Full Text] [Related]

  • 22. BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
    Tu Y, Renner S, Xu F, Fleishman A, Taylor J, Weisz J, Vescio R, Rettig M, Berenson J, Krajewski S, Reed JC, Lichtenstein A.
    Cancer Res; 1998 Jan 15; 58(2):256-62. PubMed ID: 9443402
    [Abstract] [Full Text] [Related]

  • 23. Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines.
    Shapiro GI, Koestner DA, Matranga CB, Rollins BJ.
    Clin Cancer Res; 1999 Oct 15; 5(10):2925-38. PubMed ID: 10537362
    [Abstract] [Full Text] [Related]

  • 24. Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death.
    Chen R, Keating MJ, Gandhi V, Plunkett W.
    Blood; 2005 Oct 01; 106(7):2513-9. PubMed ID: 15972445
    [Abstract] [Full Text] [Related]

  • 25. Flavopiridol displays preclinical activity in acute lymphoblastic leukemia.
    Jackman KM, Frye CB, Hunger SP.
    Pediatr Blood Cancer; 2008 Apr 01; 50(4):772-8. PubMed ID: 18000861
    [Abstract] [Full Text] [Related]

  • 26. CDK inhibitors upregulate BH3-only proteins to sensitize human myeloma cells to BH3 mimetic therapies.
    Chen S, Dai Y, Pei XY, Myers J, Wang L, Kramer LB, Garnett M, Schwartz DM, Su F, Simmons GL, Richey JD, Larsen DG, Dent P, Orlowski RZ, Grant S.
    Cancer Res; 2012 Aug 15; 72(16):4225-37. PubMed ID: 22693249
    [Abstract] [Full Text] [Related]

  • 27. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells.
    Motwani M, Delohery TM, Schwartz GK.
    Clin Cancer Res; 1999 Jul 15; 5(7):1876-83. PubMed ID: 10430095
    [Abstract] [Full Text] [Related]

  • 28. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
    Jourdan M, De Vos J, Mechti N, Klein B.
    Cell Death Differ; 2000 Dec 15; 7(12):1244-52. PubMed ID: 11175262
    [Abstract] [Full Text] [Related]

  • 29. 4-Hydroxytamoxifen inhibits proliferation of multiple myeloma cells in vitro through down-regulation of c-Myc, up-regulation of p27Kip1, and modulation of Bcl-2 family members.
    Gauduchon J, Gouilleux F, Maillard S, Marsaud V, Renoir JM, Sola B.
    Clin Cancer Res; 2005 Mar 15; 11(6):2345-54. PubMed ID: 15788686
    [Abstract] [Full Text] [Related]

  • 30. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines.
    Honoki K, Yoshitani K, Tsujiuchi T, Mori T, Tsutsumi M, Morishita T, Takakura Y, Mii Y.
    Oncol Rep; 2004 May 15; 11(5):1025-30. PubMed ID: 15069542
    [Abstract] [Full Text] [Related]

  • 31. Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1.
    MacCallum DE, Melville J, Frame S, Watt K, Anderson S, Gianella-Borradori A, Lane DP, Green SR.
    Cancer Res; 2005 Jun 15; 65(12):5399-407. PubMed ID: 15958589
    [Abstract] [Full Text] [Related]

  • 32. Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells.
    Yang C, Kaushal V, Shah SV, Kaushal GP.
    Am J Physiol Renal Physiol; 2007 Jun 15; 292(6):F1710-7. PubMed ID: 17311906
    [Abstract] [Full Text] [Related]

  • 33. [Flavopiridol, a cyclin-dependent kinase inhibitor].
    Lansiaux A, Bailly C.
    Bull Cancer; 2000 Oct 15; 87(10):697-701. PubMed ID: 11084532
    [No Abstract] [Full Text] [Related]

  • 34. The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase.
    Kaiser A, Nishi K, Gorin FA, Walsh DA, Bradbury EM, Schnier JB.
    Arch Biochem Biophys; 2001 Feb 15; 386(2):179-87. PubMed ID: 11368340
    [Abstract] [Full Text] [Related]

  • 35. Mcl-1 mediates cytokine deprivation induced apoptosis of human myeloma cell line XG-7.
    Song L, Li Y, Sun Y, Shen B.
    Chin Med J (Engl); 2002 Aug 15; 115(8):1241-3. PubMed ID: 12215301
    [Abstract] [Full Text] [Related]

  • 36. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
    Rapoport AP, Simons-Evelyn M, Chen T, Sidell R, Luhowskyj S, Rosell K, Obrig T, Hicks D, Hinkle PM, Nahm M, Insel RA, Abboud CN.
    Blood Cells Mol Dis; 2001 Aug 15; 27(3):610-24. PubMed ID: 11482875
    [Abstract] [Full Text] [Related]

  • 37. Contribution of disruption of the nuclear factor-kappaB pathway to induction of apoptosis in human leukemia cells by histone deacetylase inhibitors and flavopiridol.
    Gao N, Dai Y, Rahmani M, Dent P, Grant S.
    Mol Pharmacol; 2004 Oct 15; 66(4):956-63. PubMed ID: 15235103
    [Abstract] [Full Text] [Related]

  • 38. Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation.
    Puppo M, Pastorino S, Melillo G, Pezzolo A, Varesio L, Bosco MC.
    Clin Cancer Res; 2004 Dec 15; 10(24):8704-19. PubMed ID: 15623656
    [Abstract] [Full Text] [Related]

  • 39. Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein.
    van de Donk NW, Kamphuis MM, van Dijk M, Borst HP, Bloem AC, Lokhorst HM.
    Leukemia; 2003 Jan 15; 17(1):211-9. PubMed ID: 12529680
    [Abstract] [Full Text] [Related]

  • 40. The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines.
    König A, Schwartz GK, Mohammad RM, Al-Katib A, Gabrilove JL.
    Blood; 1997 Dec 01; 90(11):4307-12. PubMed ID: 9373241
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 20.